ClinicalTrials.Veeva

Menu

Apathy in Parkinson Disease: Clinical, Physiopathological and Pharmacological Study

Grenoble Alpes University Hospital Center (CHU) logo

Grenoble Alpes University Hospital Center (CHU)

Status

Unknown

Conditions

Apathy in Parkinson Disease

Study type

Observational

Funder types

Other

Identifiers

NCT01020682
APATHIE

Details and patient eligibility

About

Apathy has been reported to occur after subthalamic nucleus stimulation (STN-DBS), a treatment of motor complications in advanced Parkinson's disease (PD). It is not known whether postoperative apathy is related to dopamine withdrawal or a side effect of STN DBS. The researchers investigated potential predictors of apathy, and the effect of dopamine agonist treatment.

Enrollment

120 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Parkinson disease

Exclusion criteria

  • Mattis scale < 130
  • Beck scale > 20

Trial contacts and locations

1

Loading...

Central trial contact

Krack Paul, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems